Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Apabetalone in Pre-diabetes
NCT01728467Phase 2Completed
- Sponsor
- Resverlogix Corp.
- Start
- Nov 2012
- Primary completion
- Mar 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of apabetalone in prediabetes, sponsored by Resverlogix Corp.. Started Nov 2012; status: completed.
02
Drugs
apabetalone
03
Conditions
prediabetes
Beyond the preview
Go deeper on NCT01728467.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01728467.